The most popular Tel Aviv-traded share among fund managers continues to be Teva Pharmaceuticals (Nasdaq:TEVA). Meitav today published that Israeli fund managers hold NIS 271 million overall in Teva shares.

Eight of the nine largest fund managers hold Teva as one of their top five. Moreover, Teva is the leader with five fund managers, with Bezeq and Bank Hapoalim coming in second and third respectively.